Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in ACS and de Novo AF
NCT04276155Phase 4Active, not recruiting
- Sponsor
- Centre Hospitalier de Pau
- Start
- Aug 2021
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Centre Hospitalier de Pau. Primary endpoint: Occurrence of hemorrhagic events at 2 years. Started Aug 2021; status: active, not recruiting.
Beyond the preview
Go deeper on NCT04276155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04276155.